Neuralink to Test Brain Implant for Controlling Robotic Arm

Elon Musk's Neuralink has launched a feasibility trial to evaluate its brain-computer interface's ability to enable paralyzed individuals to control a robotic arm using their thoughts.

Neuralink's trial, named the CONVOY study, will test its N1 brain implant with an assistive robotic arm to restore physical freedom for individuals with paralysis.
The wireless brain-computer interface (BCI) translates neural activity into commands for external devices, eliminating the need for cumbersome cables used in earlier technologies.
Participants from Neuralink's ongoing PRIME study, which focuses on computer control via thought, are eligible to join the new robotic arm trial.
The study has received regulatory approval in both the U.S. and Canada, with Canadian neurosurgeons authorized to recruit six additional participants for testing.
Neuralink's ultimate goal is to enhance independence for individuals with severe mobility impairments, building on previous successes in computer control and gaming applications.